TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

  1. Home
  2. purchase Customization

purchase customization

Leave This Empty:

choose chapter to purchase


Back to Report

table of content

1 RNA Drugs Market Overview
1.1 Product Overview and Scope of RNA Drugs
1.2 RNA Drugs Segment by Type
1.2.1 Global RNA Drugs Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 siRNA
1.2.3 ASO
1.2.4 miRNA
1.2.5 Nucleic Acid Aptamers
1.3 RNA Drugs Segment by Application
1.3.1 Global RNA Drugs Sales Comparison by Application: (2023-2030)
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Global RNA Drugs Market Size Estimates and Forecasts
1.4.1 Global RNA Drugs Revenue 2018-2030
1.4.2 Global RNA Drugs Sales 2018-2030
1.4.3 RNA Drugs Market Size by Region: 2018 Versus 2022 Versus 2030
2 RNA Drugs Market Competition by Manufacturers
2.1 Global RNA Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global RNA Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global RNA Drugs Average Price by Manufacturers (2018-2023)
2.4 Manufacturers RNA Drugs Manufacturing Sites, Area Served, Product Type
2.5 RNA Drugs Market Competitive Situation and Trends
2.5.1 RNA Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest RNA Drugs Players Market Share by Revenue
2.5.3 Global RNA Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 RNA Drugs Retrospective Market Scenario by Region
3.1 Global RNA Drugs Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global RNA Drugs Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America RNA Drugs Market Facts & Figures by Country
3.3.1 North America RNA Drugs Sales by Country
3.3.2 North America RNA Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe RNA Drugs Market Facts & Figures by Country
3.4.1 Europe RNA Drugs Sales by Country
3.4.2 Europe RNA Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific RNA Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific RNA Drugs Sales by Region
3.5.2 Asia Pacific RNA Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America RNA Drugs Market Facts & Figures by Country
3.6.1 Latin America RNA Drugs Sales by Country
3.6.2 Latin America RNA Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa RNA Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa RNA Drugs Sales by Country
3.7.2 Middle East and Africa RNA Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global RNA Drugs Historic Market Analysis by Type
4.1 Global RNA Drugs Sales Market Share by Type (2018-2023)
4.2 Global RNA Drugs Revenue Market Share by Type (2018-2023)
4.3 Global RNA Drugs Price by Type (2018-2023)
5 Global RNA Drugs Historic Market Analysis by Application
5.1 Global RNA Drugs Sales Market Share by Application (2018-2023)
5.2 Global RNA Drugs Revenue Market Share by Application (2018-2023)
5.3 Global RNA Drugs Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer RNA Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Roche RNA Drugs Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Sanofi-Aventis
6.3.1 Sanofi-Aventis Corporation Information
6.3.2 Sanofi-Aventis Description and Business Overview
6.3.3 Sanofi-Aventis RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi-Aventis RNA Drugs Product Portfolio
6.3.5 Sanofi-Aventis Recent Developments/Updates
6.4 Abbott Laboratories
6.4.1 Abbott Laboratories Corporation Information
6.4.2 Abbott Laboratories Description and Business Overview
6.4.3 Abbott Laboratories RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Abbott Laboratories RNA Drugs Product Portfolio
6.4.5 Abbott Laboratories Recent Developments/Updates
6.5 Arrowhead Pharmaceuticals
6.5.1 Arrowhead Pharmaceuticals Corporation Information
6.5.2 Arrowhead Pharmaceuticals Description and Business Overview
6.5.3 Arrowhead Pharmaceuticals RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Arrowhead Pharmaceuticals RNA Drugs Product Portfolio
6.5.5 Arrowhead Pharmaceuticals Recent Developments/Updates
6.6 Benitec Biopharma
6.6.1 Benitec Biopharma Corporation Information
6.6.2 Benitec Biopharma Description and Business Overview
6.6.3 Benitec Biopharma RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Benitec Biopharma RNA Drugs Product Portfolio
6.6.5 Benitec Biopharma Recent Developments/Updates
6.7 Calimmune Inc
6.6.1 Calimmune Inc Corporation Information
6.6.2 Calimmune Inc Description and Business Overview
6.6.3 Calimmune Inc RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Calimmune Inc RNA Drugs Product Portfolio
6.7.5 Calimmune Inc Recent Developments/Updates
6.8 Dicerna
6.8.1 Dicerna Corporation Information
6.8.2 Dicerna Description and Business Overview
6.8.3 Dicerna RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Dicerna RNA Drugs Product Portfolio
6.8.5 Dicerna Recent Developments/Updates
6.9 Gradalis
6.9.1 Gradalis Corporation Information
6.9.2 Gradalis Description and Business Overview
6.9.3 Gradalis RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Gradalis RNA Drugs Product Portfolio
6.9.5 Gradalis Recent Developments/Updates
6.10 Quark
6.10.1 Quark Corporation Information
6.10.2 Quark Description and Business Overview
6.10.3 Quark RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Quark RNA Drugs Product Portfolio
6.10.5 Quark Recent Developments/Updates
6.11 RXi
6.11.1 RXi Corporation Information
6.11.2 RXi RNA Drugs Description and Business Overview
6.11.3 RXi RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 RXi RNA Drugs Product Portfolio
6.11.5 RXi Recent Developments/Updates
6.12 Senesco
6.12.1 Senesco Corporation Information
6.12.2 Senesco RNA Drugs Description and Business Overview
6.12.3 Senesco RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Senesco RNA Drugs Product Portfolio
6.12.5 Senesco Recent Developments/Updates
6.13 Silence Therapeutics
6.13.1 Silence Therapeutics Corporation Information
6.13.2 Silence Therapeutics RNA Drugs Description and Business Overview
6.13.3 Silence Therapeutics RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Silence Therapeutics RNA Drugs Product Portfolio
6.13.5 Silence Therapeutics Recent Developments/Updates
6.14 Silenseed
6.14.1 Silenseed Corporation Information
6.14.2 Silenseed RNA Drugs Description and Business Overview
6.14.3 Silenseed RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Silenseed RNA Drugs Product Portfolio
6.14.5 Silenseed Recent Developments/Updates
6.15 Tekmira
6.15.1 Tekmira Corporation Information
6.15.2 Tekmira RNA Drugs Description and Business Overview
6.15.3 Tekmira RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Tekmira RNA Drugs Product Portfolio
6.15.5 Tekmira Recent Developments/Updates
6.16 Alnylam Pharmaceuticals
6.16.1 Alnylam Pharmaceuticals Corporation Information
6.16.2 Alnylam Pharmaceuticals RNA Drugs Description and Business Overview
6.16.3 Alnylam Pharmaceuticals RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Alnylam Pharmaceuticals RNA Drugs Product Portfolio
6.16.5 Alnylam Pharmaceuticals Recent Developments/Updates
7 RNA Drugs Manufacturing Cost Analysis
7.1 RNA Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of RNA Drugs
7.4 RNA Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 RNA Drugs Distributors List
8.3 RNA Drugs Customers
9 RNA Drugs Market Dynamics
9.1 RNA Drugs Industry Trends
9.2 RNA Drugs Market Drivers
9.3 RNA Drugs Market Challenges
9.4 RNA Drugs Market Restraints
10 Global Market Forecast
10.1 RNA Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of RNA Drugs by Type (2023-2030)
10.1.2 Global Forecasted Revenue of RNA Drugs by Type (2023-2030)
10.2 RNA Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of RNA Drugs by Application (2023-2030)
10.2.2 Global Forecasted Revenue of RNA Drugs by Application (2023-2030)
10.3 RNA Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of RNA Drugs by Region (2023-2030)
10.3.2 Global Forecasted Revenue of RNA Drugs by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer